drugset / Trial / NCT07036419

A Trial of Remimazolam for Intraoperative Sedation in Pediatric and Adolescent Patients

NCT07036419

Phase 2/3 Completed 249 enrolled Jiangsu HengRui Medicine Co., Ltd.
RandomizedSingle-groupQuadruple-blindTreatment

Summary

The study is being conducted to evaluate the efficacy and safety of Remimazolam for intraoperative sedation in pediatric and adolescent patients.

Timeline

Start
2025-07-10
Primary completion
2026-05-27
Completion
2026-05-27

Drugs

EvaluationDrugModalityDoseRoute
Comparator Propofol Small molecule
Subject Remimazolam Small molecule

Indications

No indication recorded.